Temasek, EDBI invest US$50m in life sciences fund
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
AS part of efforts to strengthen Singapore's position as the biomedical sciences hub in Asia, the corporate investment arm of the Singapore Economic Development Board (EDB), EDBI, and Singapore investment firm, Temasek, have invested US$50 million into a life sciences fund.
The two have partnered Lightstone Ventures, a venture capitalist firm focusing on life sciences companies. Lightstone Ventures has set up a wholly owned subsidiary, Lightstone Singapore Pte Ltd, to source, fund, catalyse commercialisation and build Singapore-based life sciences firms.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Beijing’s calculated silence on the Iran war
Middle East-linked energy supply shocks put Asean Power Grid back in focus
